Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy With New Dense Vitreous Hemorrhage After Full Panretinal Photocoagulation
Latest Information Update: 06 May 2013
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 12 Dec 2012 New trial record
- 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.